RA
TOKE

Rise Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Rise Advisors’s Portfolio TOKE Stock Details TOKE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-121
Closed -$743 – 1218
2024
Q3 		$743 Buy
121
+2
+2% +$12 ﹤0.01% 1176
2024
Q2 		$676 Buy
119
+1
+0.8% +$6 ﹤0.01% 1179
2024
Q1 		$755 Hold
118
– – ﹤0.01% 1197
2023
Q4 		$685 Buy
118
+3
+3% +$17 ﹤0.01% 545
2023
Q3 		$666 Buy
115
+1
+0.9% +$6 ﹤0.01% 563
2023
Q2 		$659 Buy
114
+1
+0.9% +$6 ﹤0.01% 601
2023
Q1 		$704 Buy
113
+1
+0.9% +$7 ﹤0.01% 700
2022
Q4 		$749 Buy
112
+1
+0.9% +$7 ﹤0.01% 679
2022
Q3 		$1K Hold
111
– – ﹤0.01% 679
2022
Q2 		$1K Hold
111
– – ﹤0.01% 679
2022
Q1 		$1K Hold
111
– – ﹤0.01% 639
2021
Q4 		$1.37K Buy
+111
New +$1.48K ﹤0.01% 575

Other funds holding TOKE

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
EAM
Eschler Asset Management London, United Kingdom $100M AUM 83.94% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
OC
Oarsman Capital Milwaukee, Wisconsin $806M AUM 19.96% 1-Year Est. Return
MIA
Milestone Investment Advisors Middleton, Wisconsin $414M AUM 12.76% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Rise Advisors's TOKE Position: Q4 2024 in Review

Rise Advisors sold out of Cambria Cannabis ETF (TOKE) in Q4 2024, closing a stake of 121 shares — an estimated $743 sold.

Rise Advisors first reported a position in TOKE in Q4 2021 and held it in 12 quarters. The position peaked at $1.37K in Q4 2021. 18 funds tracked by Wall St. Rank hold TOKE as of Q4 2024.

  • Rise Advisors reported no remaining Cambria Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Rise Advisors sold 121 Cambria Cannabis ETF shares in Q4 2024, an estimated $743.
  • Rise Advisors first reported a position in Cambria Cannabis ETF in Q4 2021 and held it in 12 quarters.
  • Rise Advisors's Cambria Cannabis ETF position peaked at $1.37K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q4 2024.

Based on Rise Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.